SIS
PCRX icon

Sound Income Strategies’s Pacira BioSciences PCRX Stock Holding History

Sound Income Strategies’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.47K Buy
240
+157
+189% +$3.49K ﹤0.01% 1784
2025
Q4 		$1.59K Buy
+83
New +$1.97K ﹤0.01% 2193

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sound Income Strategies's PCRX Position: Q1 2026 in Review

Sound Income Strategies increased its Pacira BioSciences (PCRX) stake by 189% in Q1 2026, buying an estimated $3.49K and bringing the position to 240 shares worth $5.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1784.

Sound Income Strategies first reported a position in PCRX in Q4 2025 and has held it in 2 quarters since. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Sound Income Strategies held 240 shares of Pacira BioSciences worth $5.47K as of Q1 2026.
  • Sound Income Strategies bought 157 Pacira BioSciences shares in Q1 2026, an estimated $3.49K.
  • Pacira BioSciences made up ﹤0.01% of Sound Income Strategies's portfolio in Q1 2026, its #1784 holding.
  • Sound Income Strategies first reported a position in Pacira BioSciences in Q4 2025 and has held it in 2 quarters since.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Sound Income Strategies's 13F filing for Q1 2026, filed 27 Apr 2026.